Recurrent mutations in the gene encoding TSG101 have not been identified in human breast cancers, but elevated levels of TSG101 transcripts are associated with a more dismal prognosis for luminal-type breast cancers (Fig. 1A). Here, TSG101 is linked to breast carcinoma.